| Samuel Brauninger, CRNA | |
|
255 N 30th St, Laramie, WY 82072-5140 | |
| (307) 742-2141 | |
| Not Available |
| Full Name | Samuel Brauninger |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 255 N 30th St, Laramie, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477049039 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 11930 (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Medical Center Of The Rockies | Loveland, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Colorado Anesthesia Professionals Pllc | 6800878760 | 139 |
News Archive
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
Six to eight per cent of the EU population - equivalent to as many as 36 million people - suffer from one of the 5,000 to 8,000 known rare diseases. Both for the research of new treatments for rare diseases, as well as personalised medicine and the development of medicines for children, the patient groups available are often only small.
ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year agreement, Scripps will work with UC San Diego to provide outpatient and inpatient hospice care for UC San Diego patients, allowing UC San Diego physicians to better coordinate post-acute care for patients with chronic illness.
Mana Health's ManaPortal version 1.0.0, has achieved ONC HIT 2014 Edition Modular EHR certification, which designates that the software is capable of supporting eligible providers and hospitals with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act.
› Verified 1 days ago
| Entity Name | Northern Colorado Anesthesia Professionals Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851389613 PECOS PAC ID: 6800878760 Enrollment ID: O20040603001119 |
News Archive
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
Six to eight per cent of the EU population - equivalent to as many as 36 million people - suffer from one of the 5,000 to 8,000 known rare diseases. Both for the research of new treatments for rare diseases, as well as personalised medicine and the development of medicines for children, the patient groups available are often only small.
ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year agreement, Scripps will work with UC San Diego to provide outpatient and inpatient hospice care for UC San Diego patients, allowing UC San Diego physicians to better coordinate post-acute care for patients with chronic illness.
Mana Health's ManaPortal version 1.0.0, has achieved ONC HIT 2014 Edition Modular EHR certification, which designates that the software is capable of supporting eligible providers and hospitals with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act.
› Verified 1 days ago
| Entity Name | Rocky Mountain State Anesthesia Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730692054 PECOS PAC ID: 8729349444 Enrollment ID: O20180220003107 |
News Archive
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
Six to eight per cent of the EU population - equivalent to as many as 36 million people - suffer from one of the 5,000 to 8,000 known rare diseases. Both for the research of new treatments for rare diseases, as well as personalised medicine and the development of medicines for children, the patient groups available are often only small.
ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year agreement, Scripps will work with UC San Diego to provide outpatient and inpatient hospice care for UC San Diego patients, allowing UC San Diego physicians to better coordinate post-acute care for patients with chronic illness.
Mana Health's ManaPortal version 1.0.0, has achieved ONC HIT 2014 Edition Modular EHR certification, which designates that the software is capable of supporting eligible providers and hospitals with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Brauninger, CRNA 2605 Nighthawk Dr, Laramie, WY 82072-1978 Ph: (734) 216-0063 | Samuel Brauninger, CRNA 255 N 30th St, Laramie, WY 82072-5140 Ph: (307) 742-2141 |
News Archive
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
Six to eight per cent of the EU population - equivalent to as many as 36 million people - suffer from one of the 5,000 to 8,000 known rare diseases. Both for the research of new treatments for rare diseases, as well as personalised medicine and the development of medicines for children, the patient groups available are often only small.
ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year agreement, Scripps will work with UC San Diego to provide outpatient and inpatient hospice care for UC San Diego patients, allowing UC San Diego physicians to better coordinate post-acute care for patients with chronic illness.
Mana Health's ManaPortal version 1.0.0, has achieved ONC HIT 2014 Edition Modular EHR certification, which designates that the software is capable of supporting eligible providers and hospitals with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act.
› Verified 1 days ago
Ludonna K Stone, CRNA, MHS Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3508 Reynolds St, Laramie, WY 82072 Phone: 307-745-8529 Fax: 307-745-8529 | |
Ms. Bonnie Schroeder, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1154 Frontera Dr, Laramie, WY 82072 Phone: 970-380-9954 |